Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 1 I, 1999, Pages 79-87

  Hamilos, Daniel L ^a   Thawley, Stanley E ^a   Kramper, Maggie A ^a   Kamil, Asma ^b   Hamid, Qutayba A ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Cytokine; Fluticasone; Inflammation; Nasal polyps; Sinusitis

Indexed keywords

FLUTICASONE; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL INFILTRATION; CHRONIC SINUSITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EOSINOPHILIA; FEMALE; HUMAN; HUMAN TISSUE; INTRANASAL DRUG ADMINISTRATION; MALE; NOSE POLYP; PRIORITY JOURNAL; STEROID THERAPY;

EID: 0032953842     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70529-4     Document Type: Article

References (42)

1. Slavin RG. Sinusitis in adults and its relation to allergic rhinitis, asthma, and nasal polyps. J Allergy and Clin Immunol 1988;82:950-6.
2. Dolovich J, Ohtoshi T, Jordana M, Gauldie J, Denburg J. Nasal polyps: local inductive micro environment in the pathogenesis of the inflammation. In: Mygind N, Pipkorn U, editors. Rhinitis and asthma. Munksgaard: 1990; p. 233-41.
3. Harlin SL, Ansel D, Lane SR, Myers J, Kephart GM, Gleich GJ. A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. J Allergy and Clin Immunol 1988;81:867-75.
4. Hamilos DL, Leung DYM, Wood R, Meyers A, Stephens LK, Barkans J, et al. Chronic hyperplastic sinusitis: association of tissue eosinophilia and cytokine mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3. J Allergy and Clin Immunol 1992;91:39-48.
5. Dobrina A, Menegazzi R, Carlos TM, Nardon E, Cramer R, Zacchi T, et al. Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. J Clin Invest 1991;88:20-6.
6. Weller PF, Rand TH, Goelz SE, Chi-Rosso G, Lobb RR. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1. Proceedings of the National Academy of Sciences of the United States of America. 1991;88:7430-3.
7. Bochner BS, Luscinskas FW, Gimbrone MA Jr, Newman W, Sterbinsky SA, Derse-Anthony CP, et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991;173:1553-7.
8. Thornhill MH, Wellicome SM, Mahiouz DL, Lanchbury JS, Kyan-Aung U, Haskard DO. Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. J Immunol 1991;146:592-8.
9. Moser R, Fehr J, Bruijnzeel PLB. IL4 controls the selective endotheliumdriven transmigration of eosinophils from allergic individuals. J Immunol 1992;149:1432-8.
10. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel C, Klunk D, Tomioka K, et al. Interleukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. Journal of Immunology 1992;148:1086-92.
11. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 1995;154:799-803.
12. Iademarco MF, Barks JL, Dean DC. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-α in cultured endothelial cells. J Clin Invest 1995;95:264-71.
13. Barks JL, McQuillan JJ, Iademarco MF. TNF-α and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells. J Immunol 1997;159:4532-8.
14. Jahnsen FL, Haraldsen G, Aanesen JP, Haye R, Brandtzaeg P. Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Mol Cell Biol 1995;12:624-32.
15. Hamilos DL, Leung DYM, Wood R, Bean DK, Song YL, Schotman E, et al. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-α. Am J Respir Cell Mol Biol 1996;15:443-50.
16. Churchill L, Gundel RH, Letts LG, Wegner CD. Contribution of specific cell-adhesive glycoproteins to airway and alveolar inflammation and dysfunction. Am Rev Respir Dis 1993;148:883-7.
17. Fukuda T, FukushimaY, Numao T, Ando N, Arima M, Nakajima H, et al. Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma. Am J Respir Cell Mol Biol 1996;14:84-94.
18. Ying S, Meng Q, Barata LT, Robinson DS, Durham SR, Kay AB. Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Immunol 1997;158:5050-7.
19. Kitayama J, Fuhlbrigge RC, Puri KD, Springer TA. P-selectin, L-selectin, and alpha 4 integrin have distinct roles in eosinophil tethering and arrest on vascular endothelial cells under physiological flow conditions. J Immunol 1997;159:3929-39.
20. Symon FA, Walsh GM, Watson SR, Wardlaw AJ. Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent. J Exp Med 1994;180:371-6.
21. Yao L, Pan J, Setiadi H, Patel KD, McEver RP. Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J Exp Med 1996;184:81-92.
22. Johnson M. Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol 1996;97:169-76.
23. Noonan M, Chervinsky P, Busse WW, Weisberg SC, Pinnas J, deBoisblanc BP, et al. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. Am J Respir Crit Care Med 1995;152:1467-73.
24. Frew AJ, Kay AB. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol 1988;141:4158-64.
25. Moqbel R, Barkans J, Bradley BL, Durham SR, Kay AB. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma. Clin Exp Allergy 1992;22:265-73.
26. Tai P-C, Spry CJF, Teterson C, Venge P, Olssen I. Monoclonal antibodies distinguish storage and secreted forms of eosinophil cationic protein. Nature 1984;309:182-4.
27. Spry CJF, Tai P-C, Barkans J. Tissue localization of human eosinophil cationic proteins in allergic diseases. Int Arch Allergy Appl Immunol 1985;77:252-4.
28. Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
29. Bourke GJ, Daly LE, McGilvray J. Interpretation and uses of medical statistics. 3rd ed. Boston: Blackwell Scientific; 1985.
30. Kanai N, Denburg J, Jordana M, Dolovich J. Nasal polyp inflammation. Effect of topical nasal steroid. Am J Respir Crit Care Med 1994;150:1094-100.
31. Booth H, Richmond I, Ward C, Gardiner PV, Harkawat R, Walters EH. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med 1995;152:45-52.
32. Holmberg K, Julliusson S, Balder B, Smith DL, Richards DH, Karlsson G. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis. Ann Allergy Asthma Immunol 1997;78:270-6.
33. Adachi T, Motojima S, Hirata A, Fukuda T, Kihara N, Kosaku A, et al. Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5. J Allergy Clin Immunol 1996;98:S207-15.
34. Rothenberg MW, Owen WF, et al. Eosinophils co-cultured with endothelial cells have increased survival and functional properties. Science 1987;137:645-7.
35. Rothenberg MW, Owen WF, et al. Human eosinophils have prolonged survival, enhanced functional properties and become hypodense when exposed to human interleukin-3. J Clin Invest 1988;81:1986-92.
36. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219.
37. Woolley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH, Woolley MJ. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 1996;154:237-43.
38. Gille J, Paxton LL, Lawley TJ, Caughman SW, Swerlick RA. Retinoic acid inhibits the regulated expression of vascular cell adhesion molecule-1 by cultured dermal microvascular endothelial cells. J Clin Invest 1997;99:492-500.
39. Johnson DR, Douglas I, Jahnke A, Ghosh S, Pober JS. A sustained reduction in IκB-β may contribute to persistent NF-βB activation in human endothelial cells. J Biol Chem 1996;271:16317-22.
40. Read MA, Neish AS, Gerritsen ME, Collins T. Postinduction transcriptional repression of E-selectin and vascular cell adhesion molecule-1. J Immunol 1996;157:3472-9.
41. Barnes PJ, Adcock IM. NF-κB; a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci 1997;18:46-50.
42. Lukacs NW, Stricter RM, Chensue SW, Widmer M, Kunkel SL. TNF-α mediates recruitment of neutrophils and eosinophils during airway inflammation. J Immunol 1995;154:5411-7.